Tech Company Financing Transactions
NovAliX Funding Round
NovAliX, based in Strasbourg, secured investment capital from Bruker.
Transaction Overview
Company Information
Company Status
Private & Independent
Industry
Manufacturing
Mailing Address
16, rue d'Ankara
Strasbourg, 67000
France
Strasbourg, 67000
France
Phone
Website
Email Address
Overview
NovAliX is a drug discovery-focused CRO. Research and development programs around the world are gaining competitive advantage from our award-winning chemistry teams and one of the world's most comprehensive biophysics platforms.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Denis Zeyer
Chief Financial Officer
Christophe Dubost
Chief Operating Officer
Pierre Deprez
President
Stephan Jenn
Vice President
Jérôme Guillemont
Vice President
Laurent Saniere
VP - Bus. Development
Marco Pintore
VP - Finance
Carine Petiteville
VP - Human Resources
Florence Donadini
VP - R & D
Xavier Espanel
VP - R & D
Julien Marin
Browse more venture capital transactions:
Prev: 8/8/2024: VSParticle venture capital transaction
Next: 8/8/2024: CloudPay venture capital transaction
Share this article
Where The Data Comes From
We do our best to record every notable VC transaction. VC investment data records on this site are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs